Summary
- Current Price
- As of today, MBRX price is $2.68, down -44.28% in the most recent trading session on
- Current Price All-Time High
- MBRX price is currently -99.99% below its historical high of $21,555.00 set on
- Market Cap
- MBRX current market cap is $8M, up +12.21% over the past 365 days
- PE Ratio
- MBRX PE ratio is unknown
- Revenue
- MBRX current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- As of today, the next earnings release for MBRX has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Moleculin Biotech, Inc. |
| Ticker | NASDAQ: MBRX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | moleculin.com |
| Employees | 17 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $2.68 | ||
| Price, 1D Change | -44.28% | |
| $8M | ||
| - | ||
| - | ||
| 0.96 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$158.02 | ||
| EPS, 1Y Change | -948.72% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:25 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$158.02 | ||
| EPS Estimate | N/A | -$132.00 |
| EPS Est. Change | N/A | +16.47% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| $2.68 | ||
| Price Target | - | $22.00 |
| Price Tgt. Change | - | +720.90% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.87 | -$15.07 | -1,631.99% | |
| -$14.09 | -$158.02 | -1,021.53% | |
| -$132.00 | N/A | +16.47% | |
| -$121.25 | N/A | +23.27% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -93.94% | ||
| -99.45% | ||
| +12.21% | ||
| -77.64% | ||
| 0.00% | ||
| 0.00% | ||
| -948.72% | ||
| -1,681.41% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $2.68 | ||
| $11.82 | ||
| SMA 200 vs Price | +341.05% | |
| $4.39 | ||
| SMA 50 vs Price | +63.76% | |
| 0.96 | ||
| $0.39 | ||
| 58.49 | ||
| 76.66% | ||
| 131.04% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$158.02 | ||
| -$126.00K | ||
| - | ||
| -$26.64M | ||
| - | ||
| -$21.76M | ||
| - | ||
| -$26.52M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.08 | ||
| 0.97 | ||
| 0.97 | ||
| - | ||
| - | ||
| -17.44 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| -0.31 | ||
| -0.08 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $5.98M | ||
| $4.28M | ||
| $16.93M | ||
| $5.19M | ||
| $10.95M | ||
| $5.36M | ||
| $478.00K | ||
| $120.00K | ||
| $2.03M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $21.76M | ||
| $26.52M | ||
| $126.00K | ||
| $0.00 | ||
| $126.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$23.86M | ||
| -$13.00K | ||
| $4.64M | ||
| $13.00K | ||
| -$23.88M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Maxim Group | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Maxim Group | → | |
| Roth MKM | → |
Analyst sentiment
Institutional ownership
Screeners with MBRX
FAQ
What is the ticker symbol for Moleculin Biotech, Inc.?
The ticker symbol for Moleculin Biotech, Inc. is NASDAQ:MBRX
Does Moleculin Biotech, Inc. pay dividends?
No, Moleculin Biotech, Inc. does not pay dividends
What sector is Moleculin Biotech, Inc. in?
Moleculin Biotech, Inc. is in the Healthcare sector
What industry is Moleculin Biotech, Inc. in?
Moleculin Biotech, Inc. is in the Biotechnology industry
What country is Moleculin Biotech, Inc. based in?
Moleculin Biotech, Inc. is headquartered in United States
When did Moleculin Biotech, Inc. go public?
Moleculin Biotech, Inc. initial public offering (IPO) was on June 2, 2016
Is Moleculin Biotech, Inc. in the S&P 500?
No, Moleculin Biotech, Inc. is not included in the S&P 500 index
Is Moleculin Biotech, Inc. in the NASDAQ 100?
No, Moleculin Biotech, Inc. is not included in the NASDAQ 100 index
Is Moleculin Biotech, Inc. in the Dow Jones?
No, Moleculin Biotech, Inc. is not included in the Dow Jones index
When was Moleculin Biotech, Inc. last earnings report?
Moleculin Biotech, Inc.'s most recent earnings report was on August 13, 2018
When does Moleculin Biotech, Inc. report earnings?
The date for Moleculin Biotech, Inc.'s next earnings report has not been announced yet
Data Sources & References
- MBRX Official Website moleculin.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1659617/000143774925013880/0001437749-25-013880-index.htm
- MBRX Profile on Yahoo Finance finance.yahoo.com/quote/MBRX
- MBRX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mbrx